000			01485 a2200433 4500
005			20250516152606.0
264		0	_c20140103
008			201401s 0 0 eng d
022			_a1098-2264
024	7		_a10.1002/gcc.22075 _2doi
040			_aNLM _beng _cNLM
100	1		_aPedersen, Brent S
245	0	0	_aCopy neutral loss of heterozygosity is more frequent in older ovarian cancer patients. _h[electronic resource]
260			_bGenes, chromosomes & cancer _cSep 2013
300			_a794-801 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAging
650	0	4	_aCystadenocarcinoma, Serous _xgenetics
650	0	4	_aDNA-Binding Proteins _xgenetics
650	0	4	_aFemale
650	0	4	_aGene Expression
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aGenes, BRCA1
650	0	4	_aGenes, BRCA2
650	0	4	_aGerm-Line Mutation
650	0	4	_aHomologous Recombination
650	0	4	_aHumans
650	0	4	_aLoss of Heterozygosity
650	0	4	_aMiddle Aged
650	0	4	_aOvarian Neoplasms _xgenetics
700	1		_aKonstantinopoulos, Panagiotis A
700	1		_aSpillman, Monique A
700	1		_aDe, Subhajyoti
773	0		_tGenes, chromosomes & cancer _gvol. 52 _gno. 9 _gp. 794-801
856	4	0	_uhttps://doi.org/10.1002/gcc.22075 _zAvailable from publisher's website
999			_c22788881 _d22788881